9/14/2026
Psyence BioMed launches US ibogaine subsidiary
New Texas-based entity to spearhead ibogaine research and development in the US.
Topic archive
regulatory engagement
2 stories
8/19/2026
Psyence BioMed supports U.S. push for ibogaine development
U.S. federal actions could accelerate ibogaine's medical potential